NovAccess Global Inc. (XSNX)
OTCMKTS
· Delayed Price · Currency is USD
0.0003
0.00 (0.00%)
Apr 28, 2025, 11:02 AM EDT
NovAccess Global Revenue
Revenue
n/a
Revenue Growth
n/a
P/S Ratio
n/a
Revenue / Employee
n/a
Employees
3
Market Cap
18.57K
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Endo Inc. | 1.76B |
| Veradigm | 588.02M |
| Glass House Brands | 200.90M |
| Elite Pharmaceuticals | 70.00M |
| Northwest Biotherapeutics | 1.38M |
| BioStem Technologies | 301.83M |
| American Oncology Network | 1.76B |
| Silence Therapeutics | 43.26M |
NovAccess Global News
- 1 year ago - NovAccess Global Advisory on Annual Meeting of Shareholders - Accesswire
- 1 year ago - NovAccess Global Announces New License to Advance its Immunotherapy Platform - Accesswire
- 1 year ago - NovAccess Global Provides Business Updates and Announces Scheduling of Annual Meeting of Shareholders - Accesswire
- 1 year ago - NovAccess Global Announces $10.7 Million Financing - Accesswire
- 1 year ago - NovAccess Global Inc. to Present at the December 7th Virtual Investor Summit - Newsfile Corp
- 1 year ago - NovAccess Global Appoints Dr. Roscoe M. Moore, Jr. to Scientific Advisory Board - Accesswire
- 1 year ago - NovAccess Global Partners with BCN Biosciences to Expand Immunotherapy Platform - Accesswire
- 1 year ago - NovAccess Global to Participate in National Brain Tumor Society's Annual Glioblastoma Awareness Day - Accesswire